On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

Food and Drug Administration Commissioner Marty Makary has taken a personal interest in addressing hormone therapy treatment ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...

An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...